Department of Chemistry, Renmin University of China, No.59 Zhongguancun Street, 100872, Beijing, China.
National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, No.15 Datun Road, 100101, Beijing, China.
Biomaterials. 2019 Jan;190-191:86-96. doi: 10.1016/j.biomaterials.2018.10.046. Epub 2018 Nov 1.
Phototherapy has drawn increasing attention including the use of nanocarriers with high drug loading capacity and delivery efficacy for target-specific therapy. We have made use of naturally-occurring halloysite nanotubes (HNTs) to build a biomimetic nanocarrier platform for target-specific delivery of phototherapeutic agents. The HNTs were decorated with poly(sodium-p-styrenesulfonate) (PSS) to enhance the biocompatibility, and were further functionalized by lumen loading the type-II photosensitizer indocyanine green (ICG). The HNT-PSS-ICG nanocarrier, without further tethering targeting groups, was shown to associate with the membrane of giant unilamellar vesicles (GUVs) via Pickering effects. Application of HNT-PSS-ICG nanocarrier to human breast cancer cells gave rise to a cell mortality as high as 95%. The HNT-PSS-ICG nanocarrier was further coated with MDA-MB-436 cell membranes to endow it with targeting therapy performance against breast cancer, which was confirmed by in vivo experiments using breast cancer tumors in mice. The membrane-coated and biocompatible nanocarrier preferentially concentrated in the tumor tissue, and efficiently decreased the tumor volume by a combination of photodynamic and photothermal effects upon near-infrared light exposure. Our results demonstrate that the HNT-based nanocarrier by virtue of facial preparation and high loading capacity can be a promising candidate for membrane-targeting nanocarriers.
光疗受到了越来越多的关注,包括使用具有高载药量和递药效率的纳米载体进行靶向治疗。我们利用天然存在的埃洛石纳米管(HNTs)构建了一种仿生纳米载体平台,用于光疗药物的靶向递药。HNTs 被聚(苯乙烯磺酸钠)(PSS)修饰以增强生物相容性,并进一步通过内腔装载 II 型光敏剂吲哚菁绿(ICG)进行功能化。HNT-PSS-ICG 纳米载体无需进一步连接靶向基团,通过 Pickering 效应与巨大单层囊泡(GUVs)的膜结合。将 HNT-PSS-ICG 纳米载体应用于人乳腺癌细胞,导致细胞死亡率高达 95%。HNT-PSS-ICG 纳米载体进一步用 MDA-MB-436 细胞膜包覆,赋予其针对乳腺癌的靶向治疗性能,这在使用携带乳腺癌肿瘤的小鼠的体内实验中得到了证实。包覆膜的、生物相容性的纳米载体优先在肿瘤组织中浓缩,并在近红外光照射下通过光动力和光热效应的结合有效地减小肿瘤体积。我们的结果表明,基于 HNT 的纳米载体由于制备简单和高载药量,可以成为一种有前途的膜靶向纳米载体候选物。